Hematological malignancies (AML, MM, BCL-2/MYC-driven cohortsNMC, SCLC, NSCLC, CRC, NB, CRPC, TNBC, ER-positive breast cancer. This evidence concerns the gene MYC and non-small cell lung carcinoma.